Javascript must be enabled to continue!
Evaluation of The Effect of Smoking and Chronic obstructive pulmonary disease(COPD) on Lipid profile
View through CrossRef
Background: (COPD) disease is consider an important disease that threat our life in recent years and its result mostly from smoking .the patients who affected by this disease will be at higher risk of death caused by frequent exacerbation ,also chronic obstructive pulmonary disease may influence the lipid profile regardless of smoking status.Objective: To assessment the effect of COPD and smoking on lipid profile.Patients and Methods: This case control study included 50 patients suffer from (COPD) and other age- and sex-matched 50 smokers (≥ 20 pack/yeas) healthy people. Demographic and clinical data were collected through a direct interview with each participant. Fasting lipid profile was measured according to the standard protocols. Results: Mean serum level of TG and vLDL in smokers with COPD was 192.4±46.91 mg/dl and 61.8±12.23 mg/dl, respectively compared with 135.5±23.8 mg/dl and 32.68±14.8 mg/dl, respectively in smokers without COPD, with significant differences. Furthermore, the frequency of abnormal triglyceride value among smokers with COPD was 36% compared to 12% among smokers who don’t have this disease . (OR= 4.12. 95%CI= 1.47-11.55, p= 0.007). Similarly, the frequency of abnormal vLDL among smokers with COPD was 18% compared to 4.12% among smokers without COPD (OR= 5.27. 95%CI= 1.08-25.8, p= 0.040). In smokers with COPD, smoking displayed a positive significant correlation with TG (r= 0.325, p= 0.021) and vLDL (r= 0.333, p= 0.018). In smokers without COPD, smoking had a positive and marked association with TC (r= 0.377, p= 0.007) Conclusion: COPD is associated with negative effects on the lipid profile. In particular, triglycerides and very low-density lipoprotein cholesterol are mostly affected. Aside from COPD, smoking can also be associated with elevated lipids/lipoproteins that exceed normal limits at times. Keywords: COPD , smoking
Diyala Journal of Medicine
Title: Evaluation of The Effect of Smoking and Chronic obstructive pulmonary disease(COPD) on Lipid profile
Description:
Background: (COPD) disease is consider an important disease that threat our life in recent years and its result mostly from smoking .
the patients who affected by this disease will be at higher risk of death caused by frequent exacerbation ,also chronic obstructive pulmonary disease may influence the lipid profile regardless of smoking status.
Objective: To assessment the effect of COPD and smoking on lipid profile.
Patients and Methods: This case control study included 50 patients suffer from (COPD) and other age- and sex-matched 50 smokers (≥ 20 pack/yeas) healthy people.
Demographic and clinical data were collected through a direct interview with each participant.
Fasting lipid profile was measured according to the standard protocols.
Results: Mean serum level of TG and vLDL in smokers with COPD was 192.
4±46.
91 mg/dl and 61.
8±12.
23 mg/dl, respectively compared with 135.
5±23.
8 mg/dl and 32.
68±14.
8 mg/dl, respectively in smokers without COPD, with significant differences.
Furthermore, the frequency of abnormal triglyceride value among smokers with COPD was 36% compared to 12% among smokers who don’t have this disease .
(OR= 4.
12.
95%CI= 1.
47-11.
55, p= 0.
007).
Similarly, the frequency of abnormal vLDL among smokers with COPD was 18% compared to 4.
12% among smokers without COPD (OR= 5.
27.
95%CI= 1.
08-25.
8, p= 0.
040).
In smokers with COPD, smoking displayed a positive significant correlation with TG (r= 0.
325, p= 0.
021) and vLDL (r= 0.
333, p= 0.
018).
In smokers without COPD, smoking had a positive and marked association with TC (r= 0.
377, p= 0.
007) Conclusion: COPD is associated with negative effects on the lipid profile.
In particular, triglycerides and very low-density lipoprotein cholesterol are mostly affected.
Aside from COPD, smoking can also be associated with elevated lipids/lipoproteins that exceed normal limits at times.
Keywords: COPD , smoking.
Related Results
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease
Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease
Background:
In low- and middle-income countries, causes other than tobacco smoking contribute more to the development of chronic obstructive pulmonary disease (COPD). I...
FEATURES OF PATHOHISTOLOGICAL CHANGES IN LUNG TISSUE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND WITH COMORBIDITY WITH CHRONIC PANCREATITIS
FEATURES OF PATHOHISTOLOGICAL CHANGES IN LUNG TISSUE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND WITH COMORBIDITY WITH CHRONIC PANCREATITIS
In cases of comorbid acute and chronic pancreatitis (CP) and chronic obstructive pulmonary disease (COPD), pathological processes such as impaired lipid metabolism, chronic localiz...
Hubungan Derajat Merokok dengan Tingkat Keparahan Penyakit Paru Obstrukatif Kronis (PPOK) di Puskesmas Garuda Pekanbaru
Hubungan Derajat Merokok dengan Tingkat Keparahan Penyakit Paru Obstrukatif Kronis (PPOK) di Puskesmas Garuda Pekanbaru
Chronic Obstructive Pulmonary Disease (COPD) is a progressive chronic respiratory disease primarily caused by smoking and is one of the leading causes of death worldwide. In Pekanb...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...

